[The potentiation of adjuvant arthritis in rats by vasopressin and its V2 agonist].
Experiments on C57B1/6 mice and Wistar rats have demonstrated that neuropeptide vasopressin inhibits activity of antigen-specific suppressors and potentiates development of adjuvant arthritis. Vasopressin involvement in pathogenesis of autoimmunity is discussed.
Igonina
N A
NA
Evseev
V A
VA
Kulikova
O S
OS
D019264:Adoptive Transfer / Q000379:methods; D000818:Animals; D001127:Arginine Vasopressin / Q000819:agonists* / Q000494:pharmacology*; D001169:Arthritis, Experimental / Q000139:chemically induced* / Q000276:immunology; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000276:immunology; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D000939:Epitopes / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D051381:Rats; D017208:Rats, Wistar; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology
D000939:Epitopes; D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin